**Prestige Consumer Healthcare Appoints Christine Sacco as Chief Operating Officer**

Prestige Consumer Healthcare Inc. (NYSE: PBH) made a significant announcement on January 6, 2025, signaling a change in its executive team. The Company revealed that Christine Sacco, who currently serves as the Chief Financial Officer, has been appointed as the Chief Operating Officer as well, effective immediately.

Christine Sacco, aged 49, brings a wealth of experience to her new position. She initially joined the Company as the CFO in September 2016, transitioning from a role at Boulder Brands, Inc., a prominent health and wellness food manufacturer. Over her career, Sacco has garnered over 27 years of leadership experience in sectors such as consumer products and specialty pharma. Her background includes positions at Alpharma, Inc. and Ernst & Young, where she obtained a B.S. in accounting from St. Thomas Aquinas College and became a licensed CPA.

With this expanded role, Sacco’s remuneration package includes an annual base salary of $700,000, eligibility for target annual cash incentives, and participation in the Long-Term Incentive Plan. This plan encompasses annual equity awards, comprising performance stock units and restricted stock units. Notably, she has received a time-based restricted stock unit retention award valued at $1,575,000.

Regarding her new responsibilities, there are no additional agreements or relationships affecting Sacco’s appointment beyond what is detailed in the 8-K filing. Moreover, no familial relationships exist between Sacco and any Company directors or officers, and she is not engaged in any reportable transactions as per Regulation S-K Item 404(a).

Prestige Consumer Healthcare Inc.’s decision to extend Christine Sacco’s role reflects the Company’s confidence in her capabilities and strategic vision. The move aims to fortify execution of strategic initiatives and enhance operational excellence under her dual capacity as COO and CFO.

For more information about the company and its diverse portfolio of consumer healthcare brands, visit [Prestige Consumer Healthcare’s website](www.prestigeconsumerhealthcare.com).

Investors seeking further information can reach out to the Investor Relations department at Prestige Consumer Healthcare Inc. through Phil Terpolilli, CFA, at 914-524-6819 or via email at [email protected].

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Prestige Consumer Healthcare’s 8K filing here.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.